Skip to main content
Clinical Trials/ISRCTN55504164
ISRCTN55504164Completed未知

Development and evaluation of an intervention to support Adherence to treatment in adults with Cystic Fibrosis: A randomised controlled trial and parallel process evaluation

Sheffield Teaching Hospitals NSH Foundation Trust0 sites608 target enrollmentStarted: October 12, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
608

Study Overview

Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34556552/ (added 08/11/2023) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34665573/ (added 08/11/2023)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Diagnosed with CF and with data within the CF registry
  • 2. Aged 16 years and above
  • 3. Willing and able to take inhaled mucolytics or antibiotics via a chipped nebuliser (e.g. eTrack)

Exclusion Criteria

  • 1. Post-lung transplant
  • 2. People on the active lung transplant list
  • 3. Patients receiving palliative care, with palliative intent, for whom trial participation could be a burden
  • 4. Participants who lack capacity to give informed consent
  • 5. Participants using dry powder devices to take antibiotics or mucolytics

Investigators

Sponsor
Sheffield Teaching Hospitals NSH Foundation Trust

Similar Trials